| Balance Sheets | 2026-06-30 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 22,925 | |||
| Investment in marketable securities | 0 | |||
| Prepaid and other current assets | 601 | |||
| Total current assets | 23,526 | |||
| Property and equipment, net | 78 | |||
| Non-current prepaid expenses and other assets | 0 | |||
| Total non-current assets | 78 | |||
| Total assets | 23,604 | |||
| Trade payables | 614 | |||
| Accrued expenses | 815 | |||
| Employee-related obligations | 113 | |||
| Total current liabilities | 1,542 | |||
| Total liabilities | 1,542 | |||
| Additional paid-in capital | 786,307 | |||
| Accumulated other comprehensive income | 0 | |||
| Accumulated deficit | -764,245 | |||
| Total stockholders' equity | 22,062 | |||
| Total liabilities and stockholders equity | 23,604 | |||
Yarrow Bioscience, Inc. (YARW)
Yarrow Bioscience, Inc. (YARW)